WuXi PharmaTech (Cayman) Inc. Finite-Lived Intangible Asset, Expected Amortization, after Year Five
WuXi PharmaTech (Cayman) Inc. had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $11.69 million as of 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2015-04-15
- 2014-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $11.69M.
- 2013-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $3.25M.
- 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $3.63M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, after Year Five |
|---|---|
| 2014-12-31 | $11.69M 20-F · filed 2015-04-15 |
| 2013-12-31 | $3.25M 20-F · filed 2014-04-15 |
| 2012-12-31 | $3.63M 20-F · filed 2013-04-17 |